Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 39 min 31 sec ago

Cook Medical Makes Zilver(R) PTX(R) Drug-Eluting Stent Available in Canada

Thu, 06/05/2014 - 15:48
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Cook Medical launched its Zilver® PTX® Drug-Eluting Peripheral Stent in Canada at the Canadian Interventional Radiology Association (CIRA) meeting in Montreal, Canada. It’s the first drug-c...
Devices, Interventional
Cook Medical, Zilver PTX, drug eluting stent, peripheral stent

QT Vascular Announces FDA Clearance of Chocolate PTCA Balloon Catheter

Thu, 06/05/2014 - 15:43
Chocolate® PTCA FDA clearance opens large new market opportunity SINGAPORE, June 5, 2014 -- (Healthcare Sales & Marketing Network) -- QT Vascular Ltd. (QT Vascular) is pleased to announce that on 4 June 2014, its wholly owned US subsidiary, TriReme...
Devices, Interventional Cardiology, FDA
QT Vascular, TriReme Medical, Chocolate PTCA, Balloon Catheter

ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine

Thu, 06/05/2014 - 13:04
SOLO I Trial studied single-dose ORBACTIVTM (oritavancin) in the treatment of acute bacterial skin and skin structure infections caused by Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) PARSIPPANY, N.J.--(Healthcar...
Biopharmaceuticals
The Medicines Company, ORBACTIV, oritavancin, MRSA, ABSSSI

Trevi Therapeutics Announces $25 Million Series B Financing Led by TPG Biotech for Development of Nalbuphine ER

Wed, 06/04/2014 - 14:01
Company Initiating Activities for Pivotal Trials in Chronic Pruritic Conditions of Uremic Pruritus and Prurigo Nodularis NEW HAVEN, Conn.--(Healthcare Sales & Marketing Network)--Trevi Therapeutics, Inc. (“Trevi” or the “Company”), a clinical stage biot...
Biopharmaceuticals, Venture Capital
Trevi Therapeutics, Nalbuphine ER, pruritus

Cantel Medical Enters Into Definitive Agreement To Acquire PuriCore International Ltd.

Wed, 06/04/2014 - 13:56
Acquisition of UK-based automated endoscope reprocessor manufacturer significantly expands Cantel Medical's international capabilities LITTLE FALLS, N.J., June 4, 2014 -- (Healthcare Sales & Marketing Network) -- CANTEL MEDICAL CORP. (CMN), today annou...
Devices, Mergers & Acquisitions
Cantel Medical, PuriCore International Ltd, endoscope reprocessors

CenterVue Announces FDA Clearance of Next Generation Macular Integrity Assessment (MAIA)

Wed, 06/04/2014 - 13:50
State-of-the-art microperimetry monitors the course of retinal diseases and treatment efficacy SAN JOSE, Calif.--(Healthcare Sales & Marketing Network)--CenterVue, Inc. (www.centervue.com), a leader in the design and manufacture of highly automated medi...
Devices, Ophthalmology, FDA
CenterVue, Macular Integrity Assessment, MAIA , SLO , microperimetry

Complexa, Inc. Completes $13 Million Series B Financing to Further Advance Clinical Development of CXA-10

Wed, 06/04/2014 - 13:41
PITTSBURGH--(Healthcare Sales & Marketing Network)--Complexa, Inc., a clinical-stage platform anti-inflammatory and fibrotic disease-focused biopharmaceutical company, announced today that it has completed a $13 million dollar Series B financing. The compa...
Biopharmaceuticals, Venture Capital
Complexa, CXA-10

Ultrasonic BoneScalpel(TM) Making Spine Surgery Safe and Efficient

Wed, 06/04/2014 - 13:36
FARMINGDALE, N.Y., June 4, 2014 -- (Healthcare Sales & Marketing Network) -- Misonix, Inc. (MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based su...
Devices, Surgery
Misonix, BoneScalpel

HeartWare International Comments On FDA Warning Letter

Wed, 06/04/2014 - 13:28
FRAMINGHAM, Mass., June 4, 2014 -- (Healthcare Sales & Marketing Network) -- HeartWare International, Inc. (HTWR) announced that on June 3, 2014 it received a warning letter from the U.S. Food and Drug Administration (FDA) resulting from an inspection of ...
Devices, Cardiology
HeartWare International, HeartWare, ventricular assist device

Cohera Medical, Inc.(R) Appoints Richard W. Pascoe to its Board of Directors

Wed, 06/04/2014 - 13:23
PITTSBURGH, June 4, 2014 -- (Healthcare Sales & Marketing Network) -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today the appointment of Richard W. Pascoe as a member of the Compa...
Devices, Surgery, Personnel
Cohera Medical, surgical adhesive, TissuGlu

SafeWire, LLC Receives 510(k) Clearance for Y-Wire(R) 2

Tue, 06/03/2014 - 12:52
COOPER CITY, Fla., June 3, 2014 /PRNewswire-iReach/ -- SafeWire, LLC, a medical device company focused on the design and development of devices for minimally invasive spine surgery, announced today that it has received 510(k) clearance from the U.S. Food a...
Devices, Orthopaedic, Neurosurgery, FDA
SafeWire, Y-Wire 2, guidewire, spine surgery

Calhoun Vision Adds AngioDynamics President and CEO to Board of Directors

Tue, 06/03/2014 - 12:46
Joseph M. DeVivo Tapped Based on Strong Track Record of Business Growth PASADENA, Calif.--(Healthcare Sales & Marketing Network)--Calhoun Vision, the developer of groundbreaking ocular technology designed to allow cataract surgeons to adjust the power o...
Devices, Ophthalmology, Personnel
Calhoun Vision, Light Adjustable Lens, intraocular lens

Leading UCLA Physician Dr. Ian Cook Joins NeuroSigma As Chief Medical Officer and Senior Vice President

Tue, 06/03/2014 - 12:40
LOS ANGELES, June 03, 2014 -- (Healthcare Sales & Marketing Network) -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch™ eTNS™ System for the treatment of neurological and ne...
Devices, Neurology, Personnel
NeuroSigma, Monarch eTNS, trigeminal nerve stimulation

Curis Announces Executive Management Transition

Tue, 06/03/2014 - 12:36
LEXINGTON, Mass., June 3, 2014 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (CRIS), an oncology-focused company developing novel drug candidates for the treatment of human cancers, today announced the appointment of Ali Fattaey, Ph.D. as the C...
Biopharmaceuticals, Oncology, Personnel
Curis, Erivedge

Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer

Tue, 06/03/2014 - 12:31
MELBOURNE, Australia and STAMFORD, Connecticut, June 3, 2014 -- (Healthcare Sales & Marketing Network) -- Spinifex Pharmaceuticals, a pain drug development company, today announces that it has appointed Dr Ronald Marcus as Chief Medical Officer. Dr Marcus...
Biopharmaceuticals, Personnel
Spinifex Pharmaceuticals, EMA401

Covidien Announces CE Mark of Nellcor(TM) Respiration Rate Technology

Tue, 06/03/2014 - 12:26
System monitors respiration rate, oxygen saturation and pulse rate from a single, finger sensor DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc, a leading global provider of health care products and recognized innovator in patient ...
Devices, Monitoring, Regulatory
Covidien, Nellcor, Respiratory Sensor

Doctors at Community Cancer Center Treat Inoperable Lung Cancer Using TrueBeam System for Image-Guided Radiotherapy and Radiosurgery

Mon, 06/02/2014 - 20:23
NORMAL, Ill., June 2, 2014 -- (Healthcare Sales & Marketing Network) -- When a diagnostic chest X-ray revealed a nodule on his left lung, Paul Hoffman, 79, had a biopsy and soon got bad news: it was Stage 1 lung cancer. He was given two options. The fir...
Devices, Oncology
Varian Medical Systems, radiosurgery, TrueBeam, RapidArc, radiotherapy

Myriad myPath(TM) Melanoma Test Improves the Reliability of Melanoma Diagnosis

Mon, 06/02/2014 - 20:05
Pivotal Clinical Validation Data Presented at the 50th ASCO Annual Meeting SALT LAKE CITY, June 2, 2014 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today presented results from a pivotal clinical validation study of the Myr...
Diagnostics, Dermatology, Oncology
Myriad Genetics, myPath, Melanoma test, malignant melanoma

Myriad Presents Clinical Data on Myriad myRisk(TM) Hereditary Cancer Test at ASCO

Mon, 06/02/2014 - 19:56
myRisk Solves Overlap Dilemma Between Hereditary Cancer Syndromes SALT LAKE CITY, June 2, 2014 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today presented several clinical studies on the Myriad myRisk(TM) Hereditary Cancer ...
Diagnostics, Oncology
Myriad Genetics, myRisk, Hereditary Cancer test, hereditary cancer

Omeros Receives FDA Approval of Omidria(TM) for Use in Cataract and Other Intraocular Lens Replacement Procedures

Mon, 06/02/2014 - 19:43
Omeros to Host Conference Call Today at 4:30 p.m. ET SEATTLE, June 2, 2014 -- (Healthcare Sales & Marketing Network) -- Omeros Corporation (OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved Omidria™ (phenylephrine and ...
Biopharmaceuticals, Ophthalmology, FDA
Omeros Corp, Omidria, PharmacoSurgery

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong